“Biopharmaceuticals Manufacturing Consumables Testing Market Report is set to have rapid growth due to technological advancements and changing or improving regulatory requirements for analysis of raw materials required during biologics manufacturing at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Biopharmaceuticals Manufacturing Consumables Testing Market: Forecast 2019-2029: By Service (Compendial Testing, Laboratory Testing), By Raw Material Type (Excipients, API), Regions and segmental analysis.

Effective and successful biopharmaceutical production largely depends on the purity and quality of consumables used during production. With increasing problems related to the quality of new therapies such as poor solubility, increased molecular size and poor absorption properties, there is an increase in attention in the exploration of the various attributes of excipients and other raw materials.

The rapid growth of the bio pharmaceutical industry has made it necessary to keep pace with the change or improvement of regulatory requirements for the analysis of raw materials required during organic production. Consequently, manufacturers of final products require the support of the supplier qualification program to validate whether the services offered by the supplier are in compliance with the complementary monographs. This led the segment to support the supplier qualification program based on compendial methods. In addition, technological advances in analytical technologies have provided suppliers with improved capabilities to test proteins, raw materials, cell lines and other consumables used during the production of large molecules. Advances in portable Raman spectroscopy methods are one of the significant developments in this market. Agilent Technologies is one of the companies that offers products based on the principle of Raman spectroscopy.

Leading companies featured in the report include Alcami Corporation; Merck KGaA; Eurofins Scientific; Agilent Technologies; Charles River; Catalent, Inc.; Avomeen Analytical Services; BioSpectra; Pace Analytical Services, LLC and Gibraltar Laboratories

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever